PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics
Barbara Duncan joins as Chair and Stephen Dilly as Non-Executive DirectorStrategic appointments support progression of PhoreMost’s next generation degrader pipeline through preclinical development and commercialisation of its GlueSEEKER® platform
Trilobio raises $8M to deliver whole lab automation for biologists
San Francisco, US, 06 May 2025: Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, announces it has raised $8 million USD Seed investment.
Why the UK life sciences sector must collaborate with China: Insights from Cedrik Neike’s perspective
Cedrik Neike, Managing Board Member of Siemens AG and CEO of Siemens Digital Industries, has provided a compelling perspective on the indispensable role China plays in maintaining the global competitiveness of German industry.
PlaqueTec announces positive early research findings from interim analysis in BIOPATTERN trial
Pre-specified interim analysis reveals differences in protein concentration between systemic blood and blood from diseased coronary arteries
Nuclera establishes distribution network across APAC and the Middle East
Operational expansion accelerates global distribution capability to increase regional access and technical supportMultiple partnerships establish direct distribution channels in China, Japan, South Korea, Singapore and IsraelCambridge, UK, and
Deloitte 2025 Technology Fast 50: The fastest growing tech companies in the UK Applications now open!
We’re delighted to announce that nominations for the 2025 UK Technology Fast 50 awards are now open! Apply today and you could join the likes of Deliveroo, Revolut and Skyscanner as a UK Technology Fast 50 winner. Application deadline: Midnight, Friday 27 June 2025
Robot-assisted double operation is an Addenbrooke’s first
A cancer patient who underwent the first robot-assisted double operation at Addenbrooke’s Hospital said on Tuesday 29th April “I was blown away by how fast it was all over.”
People, science and building biotech
Anne Horgan, Partner at Cambridge Innovation Capital, talks about what makes her tick as an investor. She will chair the discussion on Nailing the Fundraise at BioBeat25 [hyperlink]. Co-organisers, Alisa Molotova, Start-up Mentor, and Miranda Weston-Smith, BioBeat founder chat with her about her role.
Cooling for Aesthetic Laser Systems: Meeting Huge Demands with Compact Solutions
Small and compact laser systems have become a staple of the growing aesthetics market – mostly for skin treatments like hair removal. To offer a well-balanced system, manufacturers must balance several conflicting factors. This results in high demands towards the system components.
SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers
This year’s Schizophrenia International Research Society (SIRS) 2025 Congress in Chicago brought together leading scientists and researchers, exploring the latest advancements and ongoing challenges in understanding and addressing schizophrenia. Michael Spilka, PhD. shares his key insights from SIRS 2025.
Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector
Established biotech leader with over 20 years’ experience including at OXB and LifeArc driving commercialization to support CGT downstream manufacturingMichele Pedrocchi PhD appointed as Non-Executive Chair of the Board of DirectorsBedfordshire
Sapio Sciences introduces Biorepository Management Solution in Sapio Release 25.4
Latest release of Sapio Platform streamlines sample workflows and delivers centralized, compliant biospecimen management
RxCelerate assembles a world-class scientific advisory board for its Biologics Discovery Unit
RxCelerate, the award-winning drug discovery and development platform, has unveiled a world-class Scientific Advisory Board (SAB) for its rapidly growing antibody discovery group, RxBiologics.
Unlocking the £100 billion opportunity: How continuous respiratory monitoring is transforming pharma economics
Co-authoured by Dr Steve Arlington, previously PWC, IBM and President of Pistoia Alliance
EFEC insight: China’s 91st CMEF and the future of global medical innovation
The 91st China International Medical Equipment Fair (CMEF), held from 8–11 April 2025 in Shanghai, underscored China’s growing prominence in medical technology and innovation. With nearly 5,000 companies from over 30 countries showcasing thousands of cutting-edge products, CMEF solidified its status as a global barometer for the medical device industry.
Astoriom appoints Ryan Smith as Global Head of Sales
Key appointment to support company in scaling biorepository and stability storage operations
Guardtech Group Commercial Team ready to shine as jam-packed summer exhibition schedule hots up
The Suffolk contamination control specialists are set to share their cleanroom construction products and services at shows covering Pharmaceuticals, Biotech, Chemical Process Engineering, Med-Tech, Battery Cells and more
Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain
Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signallingCompletes unique suite of rapid, scalable pain-related sodium channel assays and services to accelerate hit-to-lead and lead optimisation
BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflowEnables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing ap
Speakers announced for the BioResource Scientific Conference 2025
We are excited to present our speakers for the 3rd annual NIHR BioResource Scientific Conference, taking place online on Wednesday 25 June 2025 from 9.30am to 12.30pm.
Patient with rare inflammatory disease of the nervous system turns to music to raise funds for Addenbrooke's
Fundraiser Ben Standing first noticed something was wrong when he started veering across pavements whilst on holiday and after an inconclusive scan halted his imminent chemo treatment, he discovered he had a rare condition called CLIPPERS...
CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform
Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development
Mosaic Therapeutics in-licenses two clinical-stage oncology programs from Astex Pharmaceuticals for development as proprietary combination therapies
In-licensing transforms Mosaic from a research and platform company to a clinical-stage oncology business Mosaic will develop proprietary, targeted combination products, supported by proprietary biomarkers, to realise the full potential of the assets
Planning permission given for purpose-built cancer support centre in grounds of Addenbrooke’s Hospital, Cambridge
Planning permission for a new purpose-built cancer support centre in Cambridge has been granted.